Literature DB >> 8555603

Hematocrit as an indicator of blood volume and a predictor of intradialytic morbid events.

R R Steuer1, J K Leypoldt, A K Cheung, D H Harris, J M Conis.   

Abstract

Hematocrit (H) levels can change during hemodialysis, and these changes in H are inversely related to changes in blood volume (BV). The objectives of this study were to determine whether mean arterial pressure (MAP) decreases with decreasing BV and rising H during hemodialysis, and to determine the relationship between dialysis induced intravascular volume depletion and intradialytic morbid events (IME), defined as hypotension, cramping, or lightheadedness that led to dialysis staff intervention. We monitored H continuously using a noninvasive optical technique in 93 hemodialysis sessions in 16 patients. IME occurred in 48 sessions. MAP decreased with increasing H in 10 of 16 patients (P < 0.05), but the relationship between MAP and H varied among the patients. The rate of BV change during sessions without morbidity (5.6 +/- 3.6 [SD] %/hr) was lower (P < 0.001) than that preceding IME in the other sessions (12.2 +/- 5.5 [SD] %/hr). Twelve of 16 patients who exhibited recurrent IME during this study experienced these events when H reached a patient specific threshold. It is concluded that MAP decreases with decreasing BV and increasing H in many patients on hemodialysis, and that a high rate of BV change often indicates that IME are forthcoming. It is further hypothesized that a patient specific H threshold is indicative of a critical BV level below which certain patients experience IME.

Entities:  

Mesh:

Year:  1994        PMID: 8555603     DOI: 10.1097/00002480-199407000-00087

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  8 in total

1.  Post-burn temporal dynamics of blood plasma histamine during the initial 6 days from injury.

Authors:  Miles C Smalley; Joe Olivi; Krisi A Causa; Manoj Pathak; Cindy L Austin; Simon J Thompson
Journal:  Int J Burns Trauma       Date:  2020-06-15

2.  Intra-Dialytic Hemoglobin Changes and Cardiovascular Events: A Cohort Study on Dialysis Outcomes and Practice Patterns in Japan.

Authors:  Takashi Hara; Miho Kimachi; Tatsuyoshi Ikenoue; Tadao Akizawa; Shunichi Fukuhara; Yosuke Yamamoto
Journal:  Am J Nephrol       Date:  2019-09-05       Impact factor: 3.754

3.  Blood-volume monitoring in paediatric haemodialysis.

Authors:  Daljit K Hothi; Elizabeth Harvey; Christina M Goia; Denis Geary
Journal:  Pediatr Nephrol       Date:  2008-01-26       Impact factor: 3.714

4.  All-cause mortality in relation to changes in relative blood volume during hemodialysis.

Authors:  Priscila Preciado; Hanjie Zhang; Stephan Thijssen; Jeroen P Kooman; Frank M van der Sande; Peter Kotanko
Journal:  Nephrol Dial Transplant       Date:  2019-08-01       Impact factor: 5.992

5.  Initial Experience to Follow Lung Fluid Levels during Hemodialysis: A Possibility of Remote Dielectric Sensing-Guided Hemodialysis.

Authors:  Hayato Fujioka; Teruhiko Imamura; Tsutomu Koike; Koichiro Kinugawa
Journal:  J Cardiovasc Dev Dis       Date:  2022-02-14

6.  Reference intervals of complete blood count parameters for individuals aged 80 to 89 years in Guizhou, China: A STROBE-compliant retrospective study.

Authors:  Jinlie Long; Xiuhong Wang; Jianbo Yuan; Jianru Yang; Jie Zhou; Yuan Chen; Enxi Hu; Yuanzhong Zhou; Xun Min
Journal:  Medicine (Baltimore)       Date:  2022-10-07       Impact factor: 1.817

7.  Association of intradialytic hypotension and convective volume in hemodiafiltration: results from a retrospective cohort study.

Authors:  Franklin G Mora-Bravo; Guadalupe De-La-Cruz; Sonia Rivera; Alfonso Mariscal Ramírez; Jochen G Raimann; Héctor Pérez-Grovas
Journal:  BMC Nephrol       Date:  2012-09-10       Impact factor: 2.388

8.  The relationship between symptoms and blood pressure during maintenance hemodialysis.

Authors:  David J Meredith; Christopher W Pugh; Sheera Sutherland; Lionel Tarassenko; Jacqueline Birks
Journal:  Hemodial Int       Date:  2015-05-07       Impact factor: 1.812

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.